Variation in parathyroid hormone immunoassay results—a critical governance issue in the management of chronic kidney disease

Renal physicians strive to maintain parathyroid hormone (PTH) concentrations for patients with chronic kidney disease (CKD) within guideline limits, but poor method comparability means there is currently serious risk of clinical misclassification. The potential for under- or over-treatment is signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturgeon, Catharine M., Sprague, Stuart M., Metcalfe, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
I. Editorial Features
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203632/
https://www.ncbi.nlm.nih.gov/pubmed/22039013
http://dx.doi.org/10.1093/ndt/gfr614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203632/
https://www.ncbi.nlm.nih.gov/pubmed/22039013
http://dx.doi.org/10.1093/ndt/gfr614

Ejemplares similares